- Fund Type: Open-End Fund
- Objective: Government/Corporate
- Asset Class: Debt
- Geographic Focus: Israel
Alumot 0B Agach Medorag Lelo Menayot
+ Add to WatchlistSPRRBEQ:IT
154.03 ILs 0.59 0.38%As of 00:59:30 ET on 05/23/2013.
Snapshot for Alumot 0B Agach Medorag Lelo Menayot (SPRRBEQ)
| Year To Date: | +4.68% | 3-Month: | +3.08% | 3-Year: | +6.55% | 52-Week Range: | 136.77 - 154.62 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.65% | 1-Year: | +11.03% | 5-Year: | +7.22% | Beta vs TA-100: | 0.46 |
Fund Profile & Information for SPRRBEQ
Alumot 0B Agach Medorag Lelo Menayot is an open-end Fund incorporated in Israel.
| Inception Date: | 12-20-2004 | Telephone: | - |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | - | ||
Fundamentals for SPRRBEQ
| NAV | (on 2013-05-23) 154.03 |
|---|---|
| Assets (M) | (on 2013-04-30) 47.40 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for SPRRBEQ
No dividends reported
Fees & Expenses for SPRRBEQ
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 1.50 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for SPRRBEQ
Filing Date: 01/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| MLSRIT 5.85 05/30/23 | 1,124 | 1,389,264 | 3.197% |
| GZTIT 5.35 09/30/24 | 1,230 | 1,384,734 | 3.187% |
| AVGL 6.3 12/31/18 | 1,050 | 1,127,070 | 2.594% |
| IBLDIT 5.05 12/31/17 | 914 | 1,107,677 | 2.549% |
| MAINIT 5.15 11/30/36 | 910 | 1,046,409 | 2.408% |
| BIGIT 4.85 03/31/19 | 760 | 1,017,792 | 2.342% |
| HPLHNP 6 ½ 05/30/23 | 836 | 983,136 | 2.263% |
| BYSDIT 4.55 03/31/18 | 716 | 947,411 | 2.180% |
| PAZOIL 3.71 05/26/19 | 927 | 939,607 | 2.162% |
| HPLHNP 4.1 03/28/21 | 660 | 924,528 | 2.128% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page